{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:21:24Z","timestamp":1756383684890},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s11938-007-0058-3","type":"journal-article","created":{"date-parts":[[2008,3,18]],"date-time":"2008-03-18T09:59:28Z","timestamp":1205834368000},"page":"61-70","source":"Crossref","is-referenced-by-count":11,"title":["Crohn\u2019s disease of the esophagus"],"prefix":"10.1007","volume":"10","author":[{"given":"Kim L.","family":"Isaacs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,19]]},"reference":[{"key":"58_CR1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jama.1932.02740680019005","volume":"99","author":"B. Crohn","year":"1932","unstructured":"Crohn B, Ginzburg L, Oppenheimer G: Regional ileitis: a pathological and clinical entity. JAMA 1932, 99:1323\u20131329.","journal-title":"JAMA"},{"key":"58_CR2","first-page":"940","volume":"101","author":"C. Eggers","year":"1934","unstructured":"Eggers C: Resection of thoracic portion of oesophagus for chronic ulcer. Ann Surg 1934, 101:940\u2013944.","journal-title":"Ann Surg"},{"key":"58_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00054725-200105000-00006","volume":"7","author":"G. Decker","year":"2001","unstructured":"Decker G, Loftus EJ, Pasha T, et al.: Crohn\u2019s disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis 2001, 7:113\u2013119.","journal-title":"Inflamm Bowel Dis"},{"key":"58_CR4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00005176-200304000-00006","volume":"36","author":"K. Ramaswamy","year":"2003","unstructured":"Ramaswamy K, Jacobson K, Jevon G, Israel D: Esophageal Crohn disease in children: a clinical spectrum. J Pediatr Gastroenterol Nutr 2003, 36:454\u2013458.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"58_CR5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ibd.3780110517","volume":"11","author":"J. Remes-Troche","year":"2005","unstructured":"Remes-Troche J, Argote-Greene M, Rubio-Tapia A, et al.: Progressive dysphagia caused by isolated esophageal involvement of Crohn\u2019s disease. Inflamm Bowel Dis 2005, 11:515\u2013517.","journal-title":"Inflamm Bowel Dis"},{"key":"58_CR6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00005176-200211000-00009","volume":"35","author":"B. Abdullah","year":"2002","unstructured":"Abdullah B, Gupta S, Croffie J, et al.: The role of esophago-gastroduodenoscopy in the initial evaluation of childhood inflammatory bowel disease: a 7-year study. J Pediatr Gastroenterol Nutr 2002, 35:636\u2013640.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"58_CR7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00042737-200310000-00010","volume":"15","author":"A. Naranjo-Rodriguez","year":"2003","unstructured":"Naranjo-Rodriguez A, Solorzano-Peck G, Lopez-Rubio F, et al.: Isolated oesophageal involvement of Crohn\u2019s disease. Eur J Gastroenterol Hepatol 2003, 15:1123\u20131126.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"58_CR8","doi-asserted-by":"crossref","unstructured":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-1995. A 78-year-old woman with increasing dysphagia and odynophagia. N Engl J Med 1995, 333:1066\u20131072.","DOI":"10.1056\/NEJM199510193331608"},{"key":"58_CR9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S1590-8658(02)80210-9","volume":"34","author":"C. Knoblauch","year":"2002","unstructured":"Knoblauch C, Netzer P, Scheurer U, Seibold F: Dysphagia in Crohn\u2019s disease: a diagnostic challenge. Dig Liver Dis 2002, 34:660\u2013664.","journal-title":"Dig Liver Dis"},{"key":"58_CR10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.12968\/hmed.2005.66.5.18430","volume":"66","author":"J. Brittenden","year":"2005","unstructured":"Brittenden J, Hosker HS, Healey C, Porter G: Oesophagobronchial fistula causing cough and recurrent lower respiratory tract infections in a patient with Crohn\u2019s disease. Hosp Med 2005, 66:310\u2013311.","journal-title":"Hosp Med"},{"key":"58_CR11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0016-5085(97)70025-8","volume":"112","author":"G. Locke","year":"1997","unstructured":"Locke G, Talley N, Fett S, et al.: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997, 112:1148\u20131156.","journal-title":"Gastroenterology"},{"key":"58_CR12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2036.2006.02753.x","volume":"23","author":"C. Canavan","year":"2006","unstructured":"Canavan C, Abrams KR, Hawthorne B, et al.: Long-term prognosis in Crohn\u2019s disease: factors that affect quality of life. Aliment Pharmacol Ther 2006, 23:377\u2013385.","journal-title":"Aliment Pharmacol Ther"},{"key":"58_CR13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00042737-199603000-00007","volume":"8","author":"B.D. Breuer-Katschinski","year":"1996","unstructured":"Breuer-Katschinski BD, Hollander N, Goebell H: Effect of cigarette smoking on the course of Crohn\u2019s disease. Eur J Gastroenterol Hepatol 1996, 8:225\u2013228.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"58_CR14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bpg.2006.03.001","volume":"20","author":"M. O\u2019sullivan","year":"2006","unstructured":"O\u2019sullivan M, O\u2019Morain C: Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2006, 20:561\u2013573.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"58_CR15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.dld.2005.10.005","volume":"38","author":"R. Berni Canani","year":"2006","unstructured":"Berni Canani R, Terrin G, Borrelli O, et al.: Short-and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn\u2019s disease. Dig Liver Dis 2006, 38:381\u2013387.","journal-title":"Dig Liver Dis"},{"key":"58_CR16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0148607100024003176","volume":"24","author":"T.S. Thomas","year":"2000","unstructured":"Thomas TS, Berto E, Scribano ML, et al.: Treatment of esophageal Crohn\u2019s disease by enteral feeding via percutaneous endoscopic gastrostomy. JPEN J Parenter Enteral Nutr 2000, 24:176\u2013179.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"58_CR17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10620-006-3103-5","volume":"51","author":"A. Meyer","year":"2006","unstructured":"Meyer A, Ramzan N, Heigh R, Leighton J: Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs. Dig Dis Sci 2006, 51:168\u2013172.","journal-title":"Dig Dis Sci"},{"key":"58_CR18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/bega.2001.0184","volume":"15","author":"J.Q. Huang","year":"2001","unstructured":"Huang JQ, Hunt RH: Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician. Best Pract Res Clin Gastroenterol 2001, 15:355\u2013370.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"58_CR19","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/S0140-6736(06)68932-0","volume":"367","author":"P. Moayyedi","year":"2006","unstructured":"Moayyedi P, Talley N: Gastro-oesophageal reflux disease. Lancet 2006, 367:2086\u20132100.","journal-title":"Lancet"},{"key":"58_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00004836-199603000-00022","volume":"22","author":"M. Guslandi","year":"1996","unstructured":"Guslandi M, Tittobello A: Symptomatic response to omeprazole in inflammatory bowel disease. J Clin Gastroenterol 1996, 22:159\u2013160.","journal-title":"J Clin Gastroenterol"},{"key":"58_CR21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00054725-200105000-00004","volume":"7","author":"W. Miehsler","year":"2001","unstructured":"Miehsler W, Puspok A, Oberhuber G, Vogelsang H: Impact of different therapeutic regimens on the outcome of patients with Crohn\u2019s disease of the upper gastrointestinal tract. Inflamm Bowel Dis 2001, 7:99\u2013105.","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl1","key":"58_CR22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000089781","volume":"73","author":"E. Domenech","year":"2006","unstructured":"Domenech E: Inflammatory bowel disease: current therapeutic options. Digestion 2006, 73(Suppl 1):67\u201376.","journal-title":"Digestion"},{"key":"58_CR23","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1046\/j.1365-2036.2001.01060.x","volume":"15","author":"P.J. Rutgeerts","year":"2001","unstructured":"Rutgeerts PJ: Review article: the limitations of corticosteroid therapy in Crohn\u2019s disease. Aliment Pharmacol Ther 2001, 15:1515\u20131525.","journal-title":"Aliment Pharmacol Ther"},{"key":"58_CR24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00054725-200105000-00006","volume":"7","author":"A. Decker","year":"2001","unstructured":"Decker A, Loftus E, Pasha T, et al.: Crohn\u2019s disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis 2001, 7:113\u2013119.","journal-title":"Inflamm Bowel Dis"},{"key":"58_CR25","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.2165\/00003495-200262150-00015","volume":"62","author":"K. McKeage","year":"2002","unstructured":"McKeage K, Goa KL: Budesonide (Entocort EC Capsules): a review of its therapeutic use in the management of active Crohn\u2019s disease in adults. Drugs 2002, 62:2263\u20132282.","journal-title":"Drugs"},{"key":"58_CR26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1055\/s-2004-813548","volume":"42","author":"K. Weigand","year":"2004","unstructured":"Weigand K, Wagner-Thiessen E, Stolte M: Esophagitis in an adolescent patient with Crohn\u2019s disease after changing treatment from prednisolone to budesonide. Z Gastroenterol 2004, 42:1179\u20131181.","journal-title":"Z Gastroenterol"},{"key":"58_CR27","unstructured":"ACP\u2019s PIER: The Physicians\u2019 Information and Education Resource w\/ AHFS Dl Essentials. Philadelphia: American College of Physicians; 2006."},{"key":"58_CR28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","volume":"2","author":"M. Dubinsky","year":"2004","unstructured":"Dubinsky M: Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy and safety. Clin Gastroenterol Hepatol 2004, 2:731\u2013743.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"58_CR29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0016-5085(99)70445-2","volume":"117","author":"W.J. Sandborn","year":"1999","unstructured":"Sandborn WJ, Tremaine WJ, Wolf DC, et al.: Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn\u2019s disease. North American Azathioprine Study Group. Gastroenterology 1999, 117:527\u2013535.","journal-title":"Gastroenterology"},{"key":"58_CR30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","volume":"332","author":"B.G. Feagan","year":"1995","unstructured":"Feagan BG, Rochon J, Fedorak RN, et al.: Methotrexate for the treatment of Crohn\u2019s disease. N Engl J Med 1995, 332:292\u2013297.","journal-title":"N Engl J Med"},{"key":"58_CR31","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","volume":"342","author":"B.G. Feagan","year":"2000","unstructured":"Feagan BG, Fedorak RN, Irvine EJ, et al.: A comparison of methotrexate with placebo for the maintenance of remission in Crohn\u2019s disease. N Engl J Med 2000, 342:1627\u20131632.","journal-title":"N Engl J Med"},{"key":"58_CR32","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"D. Present","year":"1999","unstructured":"Present D, Rutgeerts P, Targan S, et al.: Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease. N Engl J Med 1999, 340:1398\u20131405.","journal-title":"N Engl J Med"},{"key":"58_CR33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0016-5085(99)70332-X","volume":"117","author":"P. Rutgeerts","year":"1999","unstructured":"Rutgeerts P, D\u2019Haens G, Targan S, et al.: Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn\u2019s disease. Gastroenterology 1999, 117:761\u2013769.","journal-title":"Gastroenterology"},{"key":"58_CR34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"S. Targan","year":"1997","unstructured":"Targan S, Hanauer S, van Deventer S, et al.: A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. N Engl J Med 1997, 337:1029\u20131035.","journal-title":"N Engl J Med"},{"key":"58_CR35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00004836-200204000-00025","volume":"34","author":"I. Ho","year":"2002","unstructured":"Ho I, Guarino D, Pertsovskiy Y, Cerulli M: Infliximab treatment of an esophagobronchial fistula in a patient with extensive Crohn\u2019s disease of the esophagus [letter]. J Clin Gastroenterol 2002, 34:488\u2013489.","journal-title":"J Clin Gastroenterol"},{"key":"58_CR36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00054725-199911000-00006","volume":"5","author":"T. Heller","year":"1999","unstructured":"Heller T, James S, Drachenberg C, et al.: Treatment of severe esophageal Crohn\u2019s disease with infliximab. Inflamm Bowel Dis 1999, 5:279\u2013282.","journal-title":"Inflamm Bowel Dis"},{"key":"58_CR37","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1023\/A:1010613823223","volume":"46","author":"D. Fefferman","year":"2001","unstructured":"Fefferman D, Shah S, Alsahlil M, et al.: Successful treatment of refractory esophageal Crohn\u2019s disease with infliximab. Dig Dis Sci 2001, 46:1733\u20131735.","journal-title":"Dig Dis Sci"},{"key":"58_CR38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00042737-200404000-00013","volume":"16","author":"A. Theodoropoulou","year":"2004","unstructured":"Theodoropoulou A, Koutroubakis I, Kouroumalis E: Treatment of oesophageal Crohn\u2019s disease with infliximab. Eur J Gastroenterol Hepatol 2004, 16:431\u2013432.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"58_CR39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0399-8320(05)80701-8","volume":"29","author":"J. Filippi","year":"2005","unstructured":"Filippi J, Mambrini P, Arab K, et al.: Treatment of oesophageal Crohn\u2019s disease by infliximab [in French]. Gastroenterol Clin Biol 2005, 29:84\u201385.","journal-title":"Gastroenterol Clin Biol"},{"key":"58_CR40","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.gastro.2005.06.064","volume":"129","author":"S. Schreiber","year":"2005","unstructured":"Schreiber S, Rutgeerts P, Fedorak R, et al.: A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn\u2019s disease. Gastroenterology 2005, 129:807\u2013818. [Published erratum appears in Gastroenterology 2005, 129:1808.]","journal-title":"Gastroenterology"},{"key":"58_CR41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","volume":"130","author":"S.B. Hanauer","year":"2006","unstructured":"Hanauer SB, Sandborn WJ, Rutgeerts P, et al.: Human antitumor necrosis factor monoclonal antibody (adalimumab) in Crohn\u2019s disease: the CLASSIC-I trial. Gastroenterology 2006, 130:323\u2013333.","journal-title":"Gastroenterology"},{"key":"58_CR42","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","volume":"121","author":"W.J. Sandborn","year":"2001","unstructured":"Sandborn WJ, Hanauer SB, Katz S, et al.: Etanercept for active Crohn\u2019s disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2001, 121:1088\u20131094.","journal-title":"Gastroenterology"},{"key":"58_CR43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cgh.2006.04.022","volume":"4","author":"P. Rutgeerts","year":"2006","unstructured":"Rutgeerts P, Sandborn W, Fedorak R, et al.: Onercept for moderate-to-severe Crohn\u2019s disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006, 4:888\u2013893.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"58_CR44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1440-1746.2002.02564.x","volume":"17","author":"C. Bariol","year":"2002","unstructured":"Bariol C, Meagher A, Vickers C, et al.: Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease. J Gastroenterol Hepatol 2002, 17:135\u2013139.","journal-title":"J Gastroenterol Hepatol"},{"key":"58_CR45","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/gast.2003.50145","volume":"124","author":"R. Farrell","year":"2003","unstructured":"Farrell R, Alsahli M, Jeen Y, et al.: Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn\u2019s disease: a randomized controlled trial. Gastroenterology 2003, 124:917\u2013924.","journal-title":"Gastroenterology"},{"key":"58_CR46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/ajr.125.2.359","volume":"125","author":"W.S. Cynn","year":"1975","unstructured":"Cynn WS, Chon H, Gureghian PH, Levin BL: Crohn\u2019s disease of the esophagus. Am J Roentgenol Radium Ther Nucl Med 1975, 125:359\u2013364.","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"58_CR47","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/00042737-199612000-00012","volume":"8","author":"M.H. Giaffer","year":"1996","unstructured":"Giaffer MH, Tindale WB, Holdsworth D: Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996, 8:1195\u20131200.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"58_CR48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","volume":"100","author":"K.R. DeVault","year":"2005","unstructured":"DeVault KR, Castell DO: Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005, 100:190\u2013200.","journal-title":"Am J Gastroenterol"},{"key":"58_CR49","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1055\/s-2007-1001267","volume":"30","author":"S. Honda","year":"1998","unstructured":"Honda S, Sugimoto K, Iwasaki H, et al.: Multiple mucosal bridge formation in the esophagus in a patient with Crohn\u2019s disease. Endoscopy 1998, 30:S37\u2013S38.","journal-title":"Endoscopy"},{"key":"58_CR50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1067\/mge.2003.205","volume":"57","author":"S. Abid","year":"2003","unstructured":"Abid S, Jafri W, Hamid S, et al.: Endoscopic features of esophageal tuberculosis. Gastrointest Endosc 2003, 57:759\u2013762.","journal-title":"Gastrointest Endosc"},{"key":"58_CR51","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1053\/gast.1996.1101982","volume":"110","author":"P.J. Kahrilas","year":"1996","unstructured":"Kahrilas PJ, Quigley EM: Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996, 110:1982\u20131996.","journal-title":"Gastroenterology"},{"key":"58_CR52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.gie.2005.07.007","volume":"62","author":"P. Chotiprashidi","year":"2005","unstructured":"Chotiprashidi P, Liu J, Carpenter S, et al.: ASGE Technology Status Evaluation Report: wireless esophageal pH monitoring system. Gastrointest Endosc 2005, 62:485\u2013487.","journal-title":"Gastrointest Endosc"},{"key":"58_CR53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1442-2050.2005.00516.x","volume":"18","author":"D.D. Ferguson","year":"2005","unstructured":"Ferguson DD: Evaluation and management of benign esophageal strictures. Dis Esophagus 2005, 18:359\u2013364.","journal-title":"Dis Esophagus"},{"key":"58_CR54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-2006-924999","volume":"38","author":"A. Ferlitsch","year":"2006","unstructured":"Ferlitsch A, Reinisch W, Puspok A, et al.: Safety and efficacy of endoscopic balloon dilation for treatment of Crohn\u2019s disease strictures. Endoscopy 2006, 38:483\u2013487.","journal-title":"Endoscopy"},{"key":"58_CR55","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.mcg.0000155128.31208.44","volume":"39","author":"V. Singh","year":"2005","unstructured":"Singh V, Draganov P, Valentine J: Efficacy and safety of endoscopic balloon dilation of symptomatic upper and lower gastrointestinal Crohn\u2019s disease strictures. J Clin Gastroenterol 2005, 39:284\u2013290.","journal-title":"J Clin Gastroenterol"},{"key":"58_CR56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s005950050056","volume":"30","author":"M. Ohta","year":"2000","unstructured":"Ohta M, Konno H, Kamiya K, et al.: Crohn\u2019s disease of the esophagus: report of a case. Surg Today 2000, 30:262\u2013267.","journal-title":"Surg Today"},{"key":"58_CR57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0016-5107(94)70059-1","volume":"40","author":"G. D\u2019Haens","year":"1994","unstructured":"D\u2019Haens G, Rutgeerts P, Geboes K, Vantrappen G: The natural history of esophageal Crohn\u2019s disease: three patterns of evolution. Gastrointest Endosc 1994, 40:296\u2013300.","journal-title":"Gastrointest Endosc"},{"key":"58_CR58","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2165\/00003495-200565160-00002","volume":"65","author":"S. Ardizzone","year":"2005","unstructured":"Ardizzone S, Porro G: Biologic therapy for inflammatory bowel disease. Drugs 2005, 65:2253\u20132286.","journal-title":"Drugs"},{"key":"58_CR59","doi-asserted-by":"crossref","unstructured":"Macdonald JK, McDonald JW: Natalizumab for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev 2006, 3:CD006097.","DOI":"10.1002\/14651858.CD006097"},{"key":"58_CR60","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","volume":"353","author":"G. Assche Van","year":"2005","unstructured":"Van Assche G, Van Ranst M, Sciot R, et al.: Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn\u2019s disease. N Engl J Med 2005, 353:362\u2013368.","journal-title":"N Engl J Med"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-007-0058-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0058-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:36Z","timestamp":1559422596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-007-0058-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1007\/s11938-007-0058-3","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}